HSBC/CALL/PFIZER INC/65/0.1/18.12.24 Stock

Warrant

DE000HG6S393

Real-time BOERSE MUENCHEN 13:35:46 2024-05-29 EDT
0.011 EUR 0.00% Intraday chart for HSBC/CALL/PFIZER INC/65/0.1/18.12.24
Date Price Change
24-05-29 0.011 0.00%
24-05-28 0.011 0.00%
24-05-27 0.011 0.00%
24-05-24 0.011 0.00%
24-05-23 0.011 0.00%

Real-time BOERSE MUENCHEN

Last update May 29, 2024 at 01:35 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer HSBC
WKN HG6S39
ISINDE000HG6S393
Date issued 2022-11-08
Strike 65 $
Maturity 2024-12-18 (203 Days)
Parity 10 : 1
Emission price 0.3
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.45
Lowest since issue 0.011
Spread 0.01
Spread %90.91%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.3 USD
Average target price
31.92 USD
Spread / Average Target
+12.78%
Consensus